Toward a Glioblastoma Vaccine: Promise and Potential Pitfalls
- 1 November 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (21) , 4240-4243
- https://doi.org/10.1200/jco.2004.06.927
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A phase II trial of thalidomide, α-Interferon +/–octreotide in patients with advanced hepatocellular carcinomaJournal of Clinical Oncology, 2004
- Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials GroupJournal of Clinical Oncology, 2004
- Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials GroupJournal of Clinical Oncology, 2004
- Cyclooxygenase-2 inhibitors in colorectal cancerSeminars in Oncology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI Journal of the National Cancer Institute, 1993